Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

计划入组 36 人 · 首次发布于 2015 年 9 月 24 日

Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD

计划入组 1,450 人 · 首次发布于 2014 年 4 月 11 日

A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province

计划入组 10 人 · 首次发布于 2024 年 9 月 19 日

PTD2

KD2-396

PKD-003

PKD Foundation

United States

Novartis Acquires Regulus Therapeutics for $800M, Expanding Kidney Disease Portfolio

Helex Secures $3.5M Seed Funding to Develop Non-Viral Gene Therapy for Polycystic Kidney Disease

USC Scientists Create Most Advanced Lab-Grown Kidney Structures with Real Function for Disease Modeling